breseq  version 0.35.4  revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log

Marginal read alignment evidence (highest frequency 20 of 188 shown, sorted by frequency from high to low)
  seq id position ref new freq score (cons/poly) reads annotation genes product
*NZ_CP0092731,217,6890GA40.0% 79.3 / 21.0 55pseudogene (2228/2243 nt)BW25113_RS25990autotransporter outer membrane beta‑barrel domain‑containing protein
*NZ_CP0092731,750,1280TA35.3% 83.9 / 25.2 51G58G (GGT→GGApykFpyruvate kinase PykF
*NZ_CP0092731,750,1190CA35.2% 108.5 / 19.9 54S55R (AGC→AGApykFpyruvate kinase PykF
*NZ_CP0092731,340,9020GA34.9% 75.1 / 10.6 43S33F (TCT→TTT) pdeRcyclic di‑GMP phosphodiesterase
*NZ_CP0092734,612,0670AG34.6% 140.0 / 25.1 78E161G (GAG→GGG) yjjJtype II toxin‑antitoxin system HipA family toxin YjjJ
*NZ_CP0092731,820,6360TC34.2% 129.3 / 19.1 73E182G (GAG→GGG) astEsuccinylglutamate desuccinylase
*NZ_CP009273748,5810TA34.2% 154.3 / 30.5 79intergenic (‑330/+60)ybgD/gltAfimbrial protein/citrate synthase
*NZ_CP0092733,578,4460AC34.1% 189.5 / 17.7 88Y580D (TAC→GAC) ggtgamma‑glutamyltransferase
*NZ_CP0092733,578,4380AC33.7% 191.9 / 18.0 92intergenic (+35/+3)yrhB/ggtYrhB family protein/gamma‑glutamyltransferase
*NZ_CP0092732,977,8000AC32.8% 121.7 / 16.0 58G384G (GGT→GGGyqeFacetyl‑CoA C‑acetyltransferase
*NZ_CP0092734,245,9890CT32.7% 80.0 / 13.7 55E136K (GAA→AAA) plsBglycerol‑3‑phosphate 1‑O‑acyltransferase PlsB
*NZ_CP0092732,826,8920TG32.6% 192.9 / 11.5 90V353G (GTG→GGG) norVanaerobic nitric oxide reductase flavorubredoxin
*NZ_CP0092732,178,7170AG32.5% 159.2 / 15.9 83S22P (TCC→CCC) thiMhydroxyethylthiazole kinase
*NZ_CP0092732,621,9790TA32.5% 119.0 / 37.9 80T107S (ACT→TCT) pdeFcyclic‑guanylate‑specific phosphodiesterase PdeF
*NZ_CP0092734,058,9580GA32.5% 155.5 / 21.5 80L57L (CTG→TTG) yihOMFS transporter
*NZ_CP0092731,155,2930AG32.2% 116.2 / 10.5 59I572T (ATC→ACC) fhuEferric‑rhodotorulic acid/ferric‑coprogen receptor FhuE
*NZ_CP0092732,178,6780TG32.1% 157.1 / 20.6 82T35P (ACC→CCC) thiMhydroxyethylthiazole kinase
*NZ_CP0092734,544,9360AG32.0% 128.9 / 19.6 76I182V (ATC→GTC) uxuRUxu operon transcriptional regulator
*NZ_CP009273653,1320AC31.9% 135.8 / 11.5 69V88G (GTG→GGG) crcBfluoride efflux transporter CrcB
*NZ_CP0092734,203,6930AC31.5% 182.7 / 18.1 92V120G (GTG→GGG) yjaBacetyltransferase

Marginal new junction evidence (sorted from low to high skew)
  seq id position reads (cov) reads (cov) score skew freq annotation gene product
* ? NZ_CP009273 = 341670743 (0.460)3 (0.140)
+191 bp
3/114 4.2 23.5% intergenic (+154/+77) yhdZ/rrf amino acid ABC transporter ATP‑binding protein/5S ribosomal RNA
?NZ_CP009273 3416716 = 42 (0.450)intergenic (+163/+68) yhdZ/rrf amino acid ABC transporter ATP‑binding protein/5S ribosomal RNA
* ? NZ_CP009273 4532499 =126 (1.340)5 (0.060) 5/478 12.8 4.1% intergenic (+49/‑433) fimE/fimA type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA
?NZ_CP009273 4532813 = 113 (1.250)intergenic (+363/‑119) fimE/fimA type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA
* ? NZ_CP009273 = 4532507129 (1.370)4 (0.040) 4/478 13.5 3.3% intergenic (+57/‑425) fimE/fimA type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA
?NZ_CP009273 = 4532803 113 (1.250)intergenic (+353/‑129) fimE/fimA type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA